The CXCL5/CXCR2 Axis Attenuates Ferroptosis in Intrahepatic Cholangiocarcinoma Through the Positive Feedback Loop Between PTGS2 Transcriptional Activation and Neutrophil Recruitment
Advanced Science · 2026-11 · 13 (64)
DOI: 10.1002/advs.77185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 17.08.2026. Verfasst von Chanqi Ye und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University, School of Medicine and Key Laboratory of Cancer Prevention and In…. Hauptthemen laut MEDLINE: Ferroptosis, Receptors, Interleukin-8B, Cholangiocarcinoma, Chemokine CXCL5. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "Pioneer" and "Leading Goose" R&D Program of Zhejiang, National Natural Science Foundation of China, Zhejiang Provincial Clinical Research Center for CANCER.
Abstract (Originalsprache)
Intrahepatic cholangiocarcinoma (ICC) presents significant therapeutic challenges due to its late‐stage diagnosis and inherent treatment resistance, resulting in dismal prognosis. While ferroptosis induction has emerged as a promising antitumor strategy, its clinical implementation in ICC has been impeded by poorly defined resistance mechanisms. Here, we systematically investigated the immunomodulatory role of the CXCL5/CXCR2 axis in governing ferroptosis susceptibility through dual mechanistical pathways. In vitro studies revealed that CXCL5/CXCR2 signaling confers ferroptosis resistance by transcriptional upregulation of prostaglandin‐endoperoxide synthase 2 (PTGS2), which can serve as a functional regulatory factor for ferroptosis. Utilizing a tumor‐immune co‐culture platform, we further demonstrated that CXCL5/CXCR2 axis‐driven recruitment of N2 tumor‐associated neutrophils (TANs) orchestrates a protective microenvironment against ferroptosis. Intriguingly, PTGS2 enhances N2 TANs chemotaxis via CCL2 and CCL7, and the recruited N2 TANs subsequently activate the NF‐κB/PTGS2 pathway, thereby establishing a synergistic positive feedback loop. Notably, combinatorial treatment with the CXCR2 antagonist SB225002 and ferroptosis inducer Erastin exhibited synergistic antitumor activity in preclinical ICC models. This study provides mechanistic insights into the ferroptosis‐immune crosstalk and proposes a novel combinatorial therapeutic paradigm for overcoming treatment resistance in ICC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University, School of Medicine and Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, Hangzhou, Zhejiang, People's Republ…
- Department of Medical Oncology, Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Zhejian…
- Department of Medical Oncology, Nanyang Second General Hospital, Nanyang, Henan, People's Republic of China.
- Department of Laboratory Medicine, Institute of Traditional Chinese Medicine of Sichuan Academy of Chinese Medicine Sciences, Chengdu, Sichuan, People's Republic of China.
- Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, People's Republic of China.
- Department of Pathology and Pathophysiology, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China.
ORCID-Profile: Yan Zhang, Ying Dong, Minghao Wang, Wenguang Fu, Jian Ruan
Förderung
- "Pioneer" and "Leading Goose" R&D Program of Zhejiang
- National Natural Science Foundation of China
- Zhejiang Provincial Clinical Research Center for CANCER
- Special Research Project of Zhejiang Cancer Foundation
Zitieren
APA
Ye, C., Lin, K., Yang, S., Zhang, Y., Gao, W., Chen, J., Dong, Y., Bai, R., Tian, Y., Wang, M., Yuan, Z., Ma, Y., He, Y., Chen, R., Fu, W., Jiang, Q., Li, Q., & Ruan, J. (2026). The CXCL5/CXCR2 Axis Attenuates Ferroptosis in Intrahepatic Cholangiocarcinoma Through the Positive Feedback Loop Between PTGS2 Transcriptional Activation and Neutrophil Recruitment. Advanced Science, 13(64). https://doi.org/10.1002/advs.77185
Vancouver
Ye C, Lin K, Yang S, Zhang Y, Gao W, Chen J, et al. The CXCL5/CXCR2 Axis Attenuates Ferroptosis in Intrahepatic Cholangiocarcinoma Through the Positive Feedback Loop Between PTGS2 Transcriptional Activation and Neutrophil Recruitment. Advanced Science. 2026;13(64). doi:10.1002/advs.77185
BibTeX
@article{Ye2026,
author = {Ye, Chanqi and Lin, Kefeng and Yang, Shuyao and Zhang, Yan and Gao, Wenli and Chen, Jiaqi and Dong, Ying and Bai, Rui and Tian, Yang and Wang, Minghao and Yuan, Zhijun and Ma, Yuxiao and He, Yuqin and Chen, Ruyin and Fu, Wenguang and Jiang, Qi and Li, Qiong and Ruan, Jian},
title = {The CXCL5/CXCR2 Axis Attenuates Ferroptosis in Intrahepatic Cholangiocarcinoma Through the Positive Feedback Loop Between PTGS2 Transcriptional Activation and Neutrophil Recruitment},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {64},
doi = {10.1002/advs.77185}
}
EUVIMED